Bausch Health shareholders elect all directors, approve executive compensation and plan amendment at annual meeting

The shareholders appointed PricewaterhouseCoopers LLP as the auditors for the Company to hold office until the close of the 2024 Annual Meeting of Shareholders and authorized the Company’s Board of Directors to fix the auditors’ remuneration. For Withheld 252,834,132 10,389,131

The shareholders elected the following individuals to the Company’s Board of Directors, to serve until the close of the Company’s 2025 Annual Meeting of Shareholders, their successors are duly elected or appointed, or such director’s earlier resignation or removal: Name For Withheld Broker Non-Votes Thomas J. Appio 181,373,219 10,918,741 70,931,303 Christian A. Garcia 181,143,285 11,148,675 70,931,303 Brett M. Icahn 170,144,670 22,147,290 70,931,303 Sarah B. Kavanagh 180,316,464 11,975,496 70,931,303 Frank D. Lee 173,147,642 19,144,318 70,931,303 Steven D. Miller 177,700,669 14,591,291 70,931,303 Richard C. Mulligan, Ph.D. 175,256,854 17,035,106 70,931,303 John A. Paulson 179,422,691 12,869,269 70,931,303 Robert N. Power 173,228,670 19,063,290 70,931,303 Amy B. Wechsler, M.D. 181,626,477 10,665,483 70,931,303

The shareholders approved, on a non-binding advisory basis, the compensation of the Company’s Named Executive Officers as disclosed in the Compensation Discussion and Analysis section, executive compensation tables and accompanying narrative discussions contained in the Management Proxy Circular and Proxy Statement. For Against Abstain Broker Non-Votes I 78,660,733 5,195,531 8,435,696 70,931,303